Walbaum, B., Acevedo, F., Medina, L., Bravo, M. L., Merino, T., Camus, M., . . . Sánchez, C. (2021). Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: A report of real world data. Ecancermedicalscience.
Chicago-stil citatWalbaum, Benjamín, et al. "Pathological Complete Response to Neoadjuvant Chemotherapy, but Not the Addition of Carboplatin, Is Associated With Improved Survival in Chilean Triple Negative Breast Cancer Patients: A Report of Real World Data." Ecancermedicalscience 2021.
MLA-referensWalbaum, Benjamín, et al. "Pathological Complete Response to Neoadjuvant Chemotherapy, but Not the Addition of Carboplatin, Is Associated With Improved Survival in Chilean Triple Negative Breast Cancer Patients: A Report of Real World Data." Ecancermedicalscience 2021.